Skip to content
DataLookout
Menu

NCT07909590

A Study Evaluating the Impact of a Painkiller Product on Quality-of-Life and Daily Functioning

StatusNot Yet Recruiting
PhaseNot specified
SponsorHALEON
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Start date pushed from Nov 2026 to Dec 2026
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Pain Intensity Before Using Panadol/Dolex
Timeframe: Within the past 1 month from time of participation
Perceived Relief From Panadol/Dolex Use
Timeframe: Within the past 1 month from time of participation
QoL Assessment After Using Panadol/Dolex Post Headache Episode
Timeframe: Within the past 1 month from time of participation

Secondary (8)

Frequency of Panadol/Dolex Use
Timepoint of Panadol/Dolex Use
Product Satisfaction
Headache Management Behaviors
User Attitudes Towards Panadol/Dolex: Trust in The Product
Show 3 moreShow less
User Attitudes Towards Panadol/Dolex: Value For Money
User Attitudes Towards Panadol/Dolex: Intention to Use Again
User Attitudes Towards Panadol/Dolex: Intention to Recommend Other Consumers

Arms and interventions

Panadol/Dolex Tablet

Participants who have taken Panadol/Dolex for at least 1 headache episode in the past 1 month.

Drugs: Paracetamol

Sites

1 site in 1 country

  • Virtual siteSingapore, Marina Centre, Singapore